Status: current, Defined. Date: 30-Jun 2017. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 1951801000168113 | emtricitabine 200 mg + tenofovir disoproxil phosphate 291 mg tablet (medicinal product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 1951811000168111 | tenofovir disoproxil phosphate 291 mg + emtricitabine 200 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| tenofovir disoproxil phosphate 291 mg + emtricitabine 200 mg tablet | Is a | tenofovir disoproxil + emtricitabine | true | Inferred relationship | Some | ||
| tenofovir disoproxil phosphate 291 mg + emtricitabine 200 mg tablet | Is a | tenofovir disoproxil phosphate 291 mg tablet | true | Inferred relationship | Some | ||
| tenofovir disoproxil phosphate 291 mg + emtricitabine 200 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| tenofovir disoproxil phosphate 291 mg + emtricitabine 200 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 2071509867 | |
| tenofovir disoproxil phosphate 291 mg + emtricitabine 200 mg tablet | has Australian BoSS | emtricitabine | true | Inferred relationship | Some | 1386936376 | |
| tenofovir disoproxil phosphate 291 mg + emtricitabine 200 mg tablet | has intended active ingredient | emtricitabine | true | Inferred relationship | Some | 1386936376 | |
| tenofovir disoproxil phosphate 291 mg + emtricitabine 200 mg tablet | has Australian BoSS | tenofovir disoproxil phosphate | true | Inferred relationship | Some | 2071509866 | |
| tenofovir disoproxil phosphate 291 mg + emtricitabine 200 mg tablet | has intended active ingredient | tenofovir disoproxil | true | Inferred relationship | Some | 2071509866 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| tenofovir disoproxil phosphate 291 mg + emtricitabine 200 mg tablet, 100 | has MPUU | True | tenofovir disoproxil phosphate 291 mg + emtricitabine 200 mg tablet | Inferred relationship | Some | 1 |
| Tenofovir EMT (GH) tablet | Is a | True | tenofovir disoproxil phosphate 291 mg + emtricitabine 200 mg tablet | Inferred relationship | Some | |
| tenofovir disoproxil phosphate 291 mg + emtricitabine 200 mg tablet, 30 | has MPUU | True | tenofovir disoproxil phosphate 291 mg + emtricitabine 200 mg tablet | Inferred relationship | Some | 1 |
Reference Sets
Medicinal product unit of use reference set
FHIR